Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
This article provides a brief summary of anatomy, purpose, and disorders of the cerebellum, also offering tips on preserving brain health.
Despite it's popularity, some individuals experience an allergic reaction to cinnamon. Learn more about the symptoms and treatments for this allergy.
Researchers at Johns Hopkins have pinpointed the protein that is responsible for brain cell death in stroke, injuries, and neurodegenerative diseases.